24/7 Market News Snapshot 04 June, 2025 – Sharps Technology Inc. Common Stock (NASDAQ:STSS)

June 4, 2025

DENVER, Colo., 04 June, 2025 (www.247marketnews.com) – (NASDAQ:STSS) are discussed in this article.
Sharps Technology Inc. (STSS) is experiencing significant momentum in the pre-market session, with shares surging to a remarkable $6.557, reflecting a 75.32% increase from the previous close of $3.740. This surge in stock price is supported by a trading volume of 3.72 million shares, indicative of heightened investor interest and confidence in the company’s prospects. As market enthusiasm builds, STSS is becoming a focal point for investors monitoring potential breakthroughs in the company’s operational advancements.

In a strategic development, Sharps Technology has proudly announced the successful execution of its first shipments of the SecureGard™ and SoloGard™ smart safety syringes. This pivotal achievement signifies the company’s entry into full-scale commercial operations and the initiation of revenue generation. The inaugural shipment, valued at $400,000, forms part of a significant five-year contract with a leading provider specializing in IV flushing solutions, covering a potential supply of up to 500 million syringes. This landmark agreement underscores Sharps’ capability to cater to the increasing demands of the healthcare market.

The SoloGard™ syringes, recognized for their innovative ultra-low waste design, are produced at Sharps’ advanced manufacturing facility, which has recently undergone substantial upgrades to improve production quality and efficiency. Additionally, Sharps has fulfilled a $100,000 order of SecureGard™ smart safety syringes for a prominent vaccine provider, further emphasizing the rising global demand for advanced safety technologies within healthcare.

In an extension of its commitment to specialized markets, the company has also commenced the shipment of 200,000 units of 1mL low dead space syringes to a leading global provider of cosmetic and medical injectables. CEO Robert Hayes remarked that these initial shipments reflect the culmination of strategic planning and operational enhancements, positioning Sharps to meet both current and future market demands effectively. The company’s trajectory indicates a promising phase of growth and innovation as it strengthens partnerships and expands its influence within the healthcare sector.

Related news for (STSS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.